ACTIVE HALF-LIFE
2-4 days
CLASSIFICATION
Non-steroidal aromatase inhibitor
DOSAGE
2.5-5 mg/day
ACNE
No
WATER RETENTION
No
HBR
No
HEPATOTOXICITY
No
AROMATIZATION
No
MANUFACTURER
Deus Medical
LAB TEST
See Document
WAREHOUSE
EU Warehouse 2
SUBSTANCE
Letrozole
,
FEMAMED 2.5 (Letrozole) is part of a class of medications known as aromatase inhibitors. It is used as a hormonal treatment for breast cancer. The growth of breast cancer is often influenced by estrogens, which are female sex hormones.
FEMAMED 2.5 works by decreasing the levels of estrogen in the body, as it inhibits the enzyme called aromatase that is responsible for estrogen production. This can help impede the growth of estrogen-dependent breast cancer.